Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 0 % of short-term debt in 2024; threshold 65 %.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2024
CURE VISION from Brussel, company number BE0834565135, closed financial year 2024 with a result of € 1,232 after tax. For that financial year CURE VISION recorded revenue of € 173,350 and equity of € -44,323. Compared with financial year 2023, the result moved from € -14,800 to € 1,232. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 24, 2025.
€ -44,323
▲ € 1,232 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1,232
▲ still € 14,800 loss in 2023
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € -60,723.
Debts at end 2024
€ 3,782
▼ 14% vs 2023
Loans from banks and other lenders, long and short.
€ 42,616
▼ 14% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 18,824
▲ 165% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Revenue | - | - | - | € 173,350 | |
| Gross margin | € -1,829 | € -7,970 | € -9,458 | € 8,254 | ▲ € 17,712 |
| Profit after taxes | € -7,870 | € -14,851 | € -14,800 | € 1,232 | ▲ € 16,031 |
| Equity | € -15,903 | € -30,755 | € -45,554 | € -44,323 | ▲ € 1,232 |
| Total debts | € 115,247 | € 120,799 | € 148,708 | € 112,060 | ▼ 25% |
| Cash | € 310 | - | € 1,085 | - | |
| Retained profit | € -32,303 | € -47,155 | € -61,954 | € -60,723 | ▲ € 1,232 |
| Bank debt | € 18,844 | € 10,160 | € 4,408 | € 3,782 | ▼ 14% |
| Balance sheet total | € 99,344 | € 90,044 | € 103,153 | € 67,737 | ▼ 34% |
By revenue, CURE VISION ranks 7th of 11 companies with main activity “Detailhandel in corrigerende brillen, lenzen en zonnebrillen” in the Brussels Region that publish figures (fiscal year 2024).
Key figures of CURE VISION, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
Ask about CURE VISION the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to CURE VISION?
What happened at CURE VISION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
CURE VISION is active according to the CBE. Legal situation: Opening faillissement.
- New annual accounts for financial year 2024: profit of € 1,232. filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Elsene. KBO
In short
From € 7,870 loss in 2021 to € 1,232 profit in 2024.
Paid € 370 in corporate taxes since 2021.
Best year ever: 2024, with € 1,232 profit.
Establishments
Establishment units
Physical locations of this company
Louizalaan 305
1050 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in the Brussels Region
Same main activity (Detailhandel in corrigerende brillen, lenzen en zonnebrillen), 188 active companies in the Brussels Region, largest first.
€ 6.1 million revenue · 2026 · Sint-Gillis (bij-Brussel)
€ 4.6 million gross margin · 2025 · Elsene
€ 2.3 million gross margin · 2025 · Watermaal-Bosvoorde
€ 1.9 million gross margin · 2025 · Watermaal-Bosvoorde
€ 776,435 gross margin · 2025 · Elsene
€ 733,811 gross margin · 2025 · Anderlecht
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- KAZEMY Zahra(oprichter) 100%
Details
- Company number
- 0834.565.135
- VAT number
- BE 0834.565.135
- Registered office
- Louizalaan 305, 1050 Brussel
- Names & denominations
- CURE VISION
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Opening faillissement
- Start date
- 16 March 2011
- Peppol
- Active · Active since 13 Oct 2025
- Contact
- curevision.be [email protected] 026116125
- Activities · NACE
Detailhandel in corrigerende brillen, lenzen en zonnebrillen
Detailhandel in fotografische en optische artikelen en in precisieinstrumenten in gespecialiseerde winkels
Overige detailhandel in nieuwe artikelen neg